Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
Clinical trial NCT06281327 · RECRUITING
Trial details
- NCT number
- NCT06281327
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2025-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.